226 related articles for article (PubMed ID: 9747342)
21. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
Zhou H
Zhonghua Shao Shang Za Zhi; 2001 Apr; 17(2):102-4. PubMed ID: 11876922
[TBL] [Abstract][Full Text] [Related]
22. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii.
Mao Y; Zhou C; Zhu L; Huang Y; Yan T; Fang J; Zhu W
Fish Shellfish Immunol; 2013 Sep; 35(3):642-52. PubMed ID: 23742867
[TBL] [Abstract][Full Text] [Related]
23. A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.
Mészáros K; Parent JB; Gazzano-Santoro H; Little R; Horwitz A; Parsons T; Theofan G; Grinna L; Weickmann J; Elsbach P
J Leukoc Biol; 1993 Dec; 54(6):558-63. PubMed ID: 8245707
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
Leeuwenberg JF; Dentener MA; Buurman WA
J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
[TBL] [Abstract][Full Text] [Related]
25. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW
J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804
[TBL] [Abstract][Full Text] [Related]
26. Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins.
Chen X; Dings RP; Nesmelova I; Debbert S; Haseman JR; Maxwell J; Hoye TR; Mayo KH
J Med Chem; 2006 Dec; 49(26):7754-65. PubMed ID: 17181157
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
28. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
Schumann RR; Lamping N; Hoess A
J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
[TBL] [Abstract][Full Text] [Related]
29. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures.
Kellogg TA; Lazaron V; Wasiluk KR; Dunn DL
Shock; 2001 Feb; 15(2):124-9. PubMed ID: 11220640
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins.
Marra MN; Thornton MB; Snable JL; Leong S; Lane J; Wilde CG; Scott RW
Blood Purif; 1993; 11(2):134-40. PubMed ID: 7506040
[TBL] [Abstract][Full Text] [Related]
31. The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.
Qi SY; Li Y; O'Connor CD
Biochem J; 1994 Mar; 298 Pt 3(Pt 3):711-8. PubMed ID: 8141787
[TBL] [Abstract][Full Text] [Related]
32. Structural and functional organization of the human neutrophil 60 kDa bactericidal/permeability-increasing protein.
Ooi CE; Weiss J; Elsbach P
Agents Actions; 1991 Sep; 34(1-2):274-7. PubMed ID: 1793043
[TBL] [Abstract][Full Text] [Related]
33. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
Elsbach P
Ciba Found Symp; 1994; 186():176-87; discussion 187-9. PubMed ID: 7768151
[TBL] [Abstract][Full Text] [Related]
34. Effects of the bactericidal/permeability-increasing protein of polymorphonuclear leukocytes on isolated bacterial cytoplasmic membrane vesicles.
in't Veld G; Mannion B; Weiss J; Elsbach P
Infect Immun; 1988 May; 56(5):1203-8. PubMed ID: 3281903
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins.
Amura CR; Kamei T; Ito N; Soares MJ; Morrison DC
J Immunol; 1998 Sep; 161(5):2552-60. PubMed ID: 9725255
[TBL] [Abstract][Full Text] [Related]
36. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense.
Elsbach P
J Leukoc Biol; 1998 Jul; 64(1):14-8. PubMed ID: 9665269
[TBL] [Abstract][Full Text] [Related]
37. Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides.
Rosenfeld Y; Lev N; Shai Y
Biochemistry; 2010 Feb; 49(5):853-61. PubMed ID: 20058937
[TBL] [Abstract][Full Text] [Related]
38. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
[TBL] [Abstract][Full Text] [Related]
39. The BPI/LBP family of proteins: a structural analysis of conserved regions.
Beamer LJ; Carroll SF; Eisenberg D
Protein Sci; 1998 Apr; 7(4):906-14. PubMed ID: 9568897
[TBL] [Abstract][Full Text] [Related]
40. Protein fusions of BPI with CETP retain functions inherent to each.
Lloyd DB; Bonnette P; Thompson JF
Biochemistry; 2006 Oct; 45(43):12954-9. PubMed ID: 17059212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
